Scientific Exchange: Concepts and Practices in the Field of Electrophysiology
-
Part 3 | Session 3 Standardized Workflow in a Multi-Operator Center
-
Part 3 | Session 4 Panel Discussion and Q&A
-
Part 4 | Session 1 Introduction and Insights From Our Experience With PulseSelect
-
Part 4 | Session 3 Not All PFA Is Created Equal: Discussion
-
Part 4 | Session 4 Implementing PulseSelect Into Daily Practice: Learnings and Early Results
-
Part 4 | Session 5 Implementing PulseSelect Into Daily Practice: Discussion
-
Part 1 | Session 1 Welcome
-
Part 1 | Session 2 Review of Affera Mapping and Ablation System and Sphere-9 Catheter
-
Part 1 | Session 3 Real-World Experience With Narration of Recorded Affera
-
Part 1 | Session 4 Data Review, Learning Curve and Clinical Evidence
-
Part 1 | Session 5 Panel Discussion and Q&A
-
Part 2 | Session 1 Welcome
-
Part 2 | Session 2 Hemolysis Pathophysiology and Clinical Implications
-
Part 2 | Session 3 Hemolysis Incidence Across PFA Technologies
-
Part 2 | Session 4 Real-World Experience With PFA and Patient Selection
-
Part 2 | Session 5 Panel Discussion and Q&A
-
Part 3 | Session 1 Welcome
Dr Devi Nair offers a comprehensive overview of lesion durability and workflow with the PulseSelect™ PFA System.
The Scientific Exchange webinar series features presentations and peer-to-peer discussions with experts on advanced concepts and practices in electrophysiology.

Learning Objectives
- Hemolysis overview: pathophysiology, detection and clinical consequences from a hematologist perspective
- Review recently presented data on durability with PulseSelect PFA Ablation Catheter
- Learn about the latest innovations in pulsed field ablation
Target Audience
- Electrophysiologists
- Cardiologists
- Fellows
- Allied Healthcare Professionals
More from this programme
Part 1
Next Era of Cardiac Ablation: Affera™ Mapping and Ablation System With Sphere-9™ Catheter Real World Experience
Part 2
Hemolysis With Different PFA Technologies: Clinical Considerations
This one-hour session provides a concise and practical overview of hemolysis including its pathophysiology, detection and clinical consequences. Gain actionable insights into hemolysis and PFA technologies through a review of preclinical data as well as real-world strategies for patient selection and procedural optimization.
Part 3
Durability Study With PulseSelect Pulsed Field Ablation (PFA) System and Real-World Experience
This program features presentations and interactive discussion focused on the recently presented data on PulseSelect PFA system and new clinical research on durability with PFA. Faculty also discuss efficiency workflow tips and a multi-user center’s real-world experience.
Part 4
PulseSelect PFA: Rapid Adoption in Everyday Practice With a Dedicated EP Catheter
Learn about the unique value of the PulseSelect PFA system as a dedicated EP technology specifically designed for Pulsed Field Ablation (PFA). Hear from expert users how the PulseSelect technology facilitates easy adoption of PFA into various EP workflows, enabling its daily use with minimal learning curves and consistent performance. See cases-in-the-box featuring practical tips for safe, effective and efficient PFA procedures.
Faculty Biographies

Devi Nair
Director of Cardiac Electrophysiology
Dr Devi Nair is a cardiologist and the Director of Cardiac Electrophysiology at St Bernard's Heart and Vascular Center in Arkansas, US. She also holds the position of Assistant Professor of Medicine at the University of Arkansas for Medical Sciences. As an international leader in cardiac rhythm management, Dr Nair specialises in cardiac devices and cardiac ablation therapy.
Dr Nair has made significant contributions to the field through her numerous publications in leading international medical journals. Her extensive medical training began at the University of Kerala, India, followed by residencies at Columbia University College of Physicians & Surgeons and St Luke's Roosevelt Hospital Center in New York, US. She further honed her expertise with fellowships at Case Western Reserve University, US.